Vol 2002, No 24 (2002)

Table of Contents

Research & Development

AxCell in collaboration with Mount Sinai School of Medicine Abstract pdf
Business Review Editor
Cohesion and Zycos in PEG drug delivery collaboration Abstract pdf
Business Review Editor
Neurocrine and Wyeth extend EAAT-3 agreement Abstract pdf
Business Review Editor

Licensing

Xenova out-licenses preclinical technology to Genentech Abstract pdf
Business Review Editor
Aventis to co-market Genta’s Genasense™ Abstract pdf
Business Review Editor
King acquires Ortho-Prefest® from J&J Abstract pdf
Business Review Editor
Immunex sells cancer drug to Schering AG for US$380 M Abstract pdf
Business Review Editor

General

Drug Royalty Companies Abstract
Business Review Editor
New Chemical Entities as Potential Opportunities for Drug Delivery Companies Abstract
Business Review Editor
Therapy Focus: Anticancer Abstract
Business Review Editor

Mergers & Acquisitions

IntraBiotics acquires Apothogen Abstract pdf
Business Review Editor
Abbott to take full control of Hokuriku Seiyaku Abstract pdf
Business Review Editor

Company Profile

Kyowa Hakko Kogyo Co., Ltd Abstract pdf
Business Review Editor

Distribution & Marketing

Mayne Pharma to market Virulizin® in Brazil Abstract pdf
Business Review Editor
OM Pharma to promote Gynazole-1 treatment in Latin America and Middle East Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.